M
Maribel Rodriguez-Torres
Researcher at San Juan Bautista School of Medicine
Publications - 138
Citations - 13678
Maribel Rodriguez-Torres is an academic researcher from San Juan Bautista School of Medicine. The author has contributed to research in topics: Ribavirin & Hepatitis C. The author has an hindex of 44, co-authored 137 publications receiving 13171 citations. Previous affiliations of Maribel Rodriguez-Torres include Consejo Nacional de Ciencia y Tecnología & Pontifical Catholic University of Puerto Rico.
Papers
More filters
Journal ArticleDOI
507 Early prediction of sustained virological response (SVR) during treatment with peginterferon alfa-2A (40KD) (PEGASYS®) plus ribavirin (RBV) (COPEGUS®) in patients with HCV/HIV co-infection: Results from the aids pegasys ribavirin international co-infectio (abstract withdrawn)
Maribel Rodriguez-Torres,Francesca J. Torriani,Eduardo Lissen,Norbert Bräu,Mark S. Sulkowski,Ricard Solà,Bonaventura Clotet,Nathan Clumeck,David A. Cooper,Douglas T. Dieterich +9 more
Journal Article
Novel protease and polymerase inhibiting agents to treat chronic hepatitis C infection
C. J. Weegink,N. Forestier,P. L. Jansen,Stefan Zeuzem,Henk W. Reesink,Ira M. Jacobson,Gregory T. Everson,Stuart C Gordon,Robert S. Kauffman,Lindsay McNair,Andrew J. Muir,John G. McHutchison,Christophe Hézode,Peter Ferenci,Geoffrey Dusheiko,Stanislas Pol,T. Goeser,Jean-Pierre Bronowicki,S. Gharakhanian,D. Devonish,John Alam,Jean-Michel Pawlotsky,Tara L. Kieffer,Y. Zhou,E. Zhang,M. Marcial,R. Byrn,T. Pfeiffer,J. Miller,A. Tigges,D. Bartels,A. Kwong,Geoffrey Dusheiko,D. N. Standring,V. Bichko,R. Chase,M. LaColla,L. Lallos,A. Skelton,M. Soukasakos,M. Tausek,X. Tong,R. Ralston,Fred Poordad,Eric Lawitz,Norman Gitlin,Maribel Rodriguez-Torres,T. Box,T. Nguyen,K. Pietropaolo,W. Liu,B. A. Fielman,D. Mayers,Paul J. Pockros,David R. Nelson,E. Godofsky,Gregory T. Everson,Michael W. Fried,Reem Ghalib,Stephen A. Harrison,L. Nyberg,Mitchell L. Shiffman,G. Z. Hill,A. Chan +63 more
TL;DR: This study confirmed the potent antiviral effects of telaprevir in CHC patients, and additionally showed that these effects were enhanced when combined with Peg-IFN, and showed that the initial antiviral response was attributed to a potent inhibition of wild-type HCV.
Journal ArticleDOI
73 worldwide experience treating chronic hepatitis c (chc) with peginterferon alfa/ribavirin: final results from 7163 naive, mono-infected patients enrolled in the large multinational prophesys cohort study
Patrick Marcellin,Hugo Cheinquer,Manuela Curescu,G.M. Dusheiko,Peter Ferenci,Andrzej Horban,Donald M. Jensen,Gabriella Lengyel,Alessandra Mangia,Denis Ouzan,M. Puoti,Maribel Rodriguez-Torres,Mitchell L. Shiffman,M. Schmitz,Fernando Tatsch,M. Rizzetto +15 more
Journal ArticleDOI
296 peginterferon alfa-2a (40kd) plus 800 or 1000/1200 mg/day rbv in g1 hiv-hcv-co-infected patients: early responses to treatment and predictability for svr in the paradigm study
Maribel Rodriguez-Torres,Jihad Slim,L. Bhatti,Richard K. Sterling,Tarek Hassanein,Bonaventura Clotet,T. Branco,A. Bertasso,S. Stancic,Mark S. Sulkowski +9 more
TL;DR: Fundacion de Investigacion De Diego Santurce, Puerto Rico and Ponce School of Medicine, Santurces, PR, USA; St. Michael's Medical Center, Newark, NJ,USA; AIDS Healthcare Foundation, LA, CA, USA ; Virginia Commonwealth University, Richmond, VA, USA'; University of California San Diego, San Diego; Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Journal ArticleDOI
514 Interferon-Free Regimens of Abt-450/R, Abt-267, Abt-333, and Ribavirin Achieve High Sustained Virologic Response 4 Weeks Post-Treatment (SVR4) Rates in Patients With Chronic HCV Genotype 1 Regardless of Race, Ethnicity, or Other Baseline Characteristics
Maribel Rodriguez-Torres,Frederick A. Nunes,Daniel Cohen,Wangang Xie,Christal Marincic,Amit Khatri,Tami Pilot-Matias,Thomas Podsadecki,Bernstein Barry M +8 more